Evaluation of thyroid hormone induced pharmacological preconditioning on cardiomyocyte protection against ischemic-reperfusion injury

Indian Journal of Pharmacology

Volumn 44, Issue 1, 2012, Pages 68-72

  Kumar, Anil ^a   Taliyan, Rajeev ^a   Sharma, P L ^a  

^a ISF COLLEGE OF PHARMACY   (India)

Author keywords

Ischemic preconditioning; mPTP opening; myocardial infarction; pharmacological preconditioning

Indexed keywords

ATRACTYLOSIDE; CREATINE KINASE; LACTATE DEHYDROGENASE; LEVOTHYROXINE; THYROXINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; ISCHEMIC PRECONDITIONING; MALE; NONHUMAN; RAT; REPERFUSION INJURY; THYROXINE BLOOD LEVEL;

EID: 84863048397     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.91870     Document Type: Article

References (25)

1. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global burden of disease study. Lancet 1997;349:1498-504. (Pubitemid 27216360)
2. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-36. (Pubitemid 17174962)
3. ATP channels in cardioprotective effect of remote aortic preconditioning in isolated rat heart. J Cardiovasc Dis Res 2010;1:145-51.
4. Pantos CI, Malliopoulou VA, Mourouzis IS, Karamanoli EP, Paizis, IA, Steimberg N. Long-term Thyroxine administration protects the heart in a pattern similar to ischemic preconditioning. Thyroid 2002;12:325-9. (Pubitemid 34438937)
5. Dreixler JC, Shaikh AR, Shenoy, SK, Shen Y, Roth S. Protein kinase C subtypes and retinal ischemic preconditioning. Exp Eye Res 2008; 87:300-11.
6. Uchiyama Y, Otani H, Wakeno M, Okada T, Uchiyama T, Sumida T, et al. Role of mitochondrial K ATP channels and protein kinase C in ischaemic preconditioning. Clin Exp Pharmacol Physiol 2003;30:426-36. (Pubitemid 36714003)
7. Javadov SA, Clarke S, Das M, Griffiths EJ, Lim KH, Halestrap AP. Ischemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart. J Physiol 2003;549:513-24. (Pubitemid 36701762)
8. Halestrap AP, Clarke, SJ, Javadov SA. Mitochondrial permeability transition pore opening during myocardial reperfusion: A target for cardioprotection. Cardiovasc Res 2004;61:372-85. (Pubitemid 38210145)
9. Crompton M, Costi A. Kinetic evidence for a heart mitochondrial pore activated by Ca 2+, inorganic phosphate and oxidative stress.A potential mechanism for mitochondrial dysfunction during cellular Ca 2+ overload. Eur J Biochem 1988;178:489-501. (Pubitemid 19021853)
10. Langendorff O. Untersuchungen am uberlebenden Saugethierherzen. Pflugers Arch 1895;61:291-332.
11. Skrzypiec-Spring M, Grotthus B, Szela̧g A, SchulzR. Isolated heart perfusion according to Langendorff-Still viable in the new millennium. J Pharmacol Toxicol Methods 2007;55:113-26. (Pubitemid 46227990)
12. King JA. A routine method for estimation of lactate dehydrogenase activity. J Med Lab Technol 1959;16:265-72.
13. Hughes BP. A method for the estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera. Clin Chim Acta 1962;7:597-603.
14. Pantos C, Mourouzis I, Saranteas T. Thyroid hormone receptors alpha1 and beta1 are down regulated in the postinfarcted rat heart: Consequences on the response to ischaemia reperfusion. Basic Res Cardiol 2005;100:422-32. (Pubitemid 41300497)
15. Fishbein MC, Meerbaum S, Rit J, Lando U, Kanmatsuse K, Merair JC, et al. Early phase acute myocardial infarct size quantification: Validation of the triphenyltetrazolium chloride tissue enzyme staining technique. Am Heart J 1981;101:593-600. (Pubitemid 11120523)
16. Przyklenk K, Baurer B, Ovize M, Kloner RA, Whittaker P. Regional ischemic "preconditioning" protects remote virgin myocardium from subsequent sustained coronary occlusion.Circulation 1993;87:893-9. (Pubitemid 23070821)
17. Weinbrenner C, Nelles M, HerzogN, Sarvary L, Strasser RH. Remote preconditioning by infrarenal occlusion of the aorta protects the heart from infarction: A newly identified non-neuronal but PKC-dependent pathway. Cardiovasc Res 2002;55:590-601. (Pubitemid 34874955)
18. Sharma A, Singh M. Possible mechanism of cardioprotective effect of ischemic preconditioning in isolated rat heart. Eur J Pharmacol 2000;406:85-92.
19. Neely JR, Rovetto MJ. Techniques for perfusion isolated rat hearts. In: Hardman JG, O'Malley BW, editors. Methods in Enzymology. Vol. 39. New York: Academic Press; 1975. p. 43.
20. Verdouw PD, Van den Deol MA, De Zeeu WS, Dunker DJ.Animal models in the study of myocardial ischemia and ischemic syndromes. Cardiovasc Res 1998;62:H2312-7.
21. Pantos C, Malliopoulou V, Varonos DD, Cokkinos DV. Thyroid hormone and phenotypes of cardioprotection. Basic Res Cardiol 2004;99:101-20. (Pubitemid 38325024)
22. Morkin E, Pennock GD, Spooner PH, Bahl JJ, Goldman S. Clinical and experimental studies on the use of 3,5-diiodothyropropionic acid, a thyroid hormone analogue, in heart failure. Thyroid 2002;12:527-33. (Pubitemid 34721552)
23. Kawamura S, Yoshida KI, Miura T, Mizukami Y, Matsuzaki M. Ischemic preconditioning translocates PKC and-ε, which mediate functional protection in isolated rat heart. Am J Physiol 1998;275:H2266-71.
24. Pantos CI, Malliopoulou VA, Mourouzis IS, Karamanoli EP, Tzeis SM, Carageorgiou HC. Long-term Thyroxine administration increases heat stress protein-70 mRNA expression and attenuates p38 MAP kinase activity in response to ischaemia. J Endocrinol 2001;170:207-15. (Pubitemid 32677582)
25. Zhao J, Renner O, Wightman L, Sugden P, Stewart L, Latchman D, et al.The expression of constitutively active isotypes of protein kinase C to investigate preconditioning. J Biol Chem 1998;273:23072-9. (Pubitemid 28417487)